SELLAS Life Sciences Group, Inc. Common Stock (NASDAQ: SLS) last traded at $12.41, up 4.02% on the session. The quote above updates while this page is open; the figures below are drawn from SELLAS Life Sciences Group, Inc. Common Stock’s own filings and are restated only when a new one is published.
SELLAS Life Sciences Group, Inc. Common Stock trades on NASDAQ under the ticker SLS. Its market capitalisation is $2.51 billion.
Valuation measures for SELLAS Life Sciences Group, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.51B |
|---|---|
| Enterprise value | $2.38B |
| Price / book | 18.21 |
| Beta | 1.91 |
Trailing-twelve-month figures tagged in SELLAS Life Sciences Group, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$32.46M |
| EPS (TTM) | -$0.210 |
|---|
| Return on equity | -23.58% |
|---|
| Cash | $138.34M |
|---|
Range and volume for SLS over the past 52 weeks.
| 52-week high | $15.88 |
|---|---|
| 52-week low | $1.39 |
| Volume | 6.36M |
| Average volume | 6.46M |
| Previous close | $11.93 |
Invest a chosen dollar amount in SELLAS Life Sciences Group, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell SLS.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.